Precision TMS with integrated visualization and analysis of real-time E-field and EEG source imaging
Active Project Grant Awarded Last action
- Award ID
- R01MH136160
- Recipient
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,581,923
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date 35% complete
- Place of performance
- Winter Hill, MA 02145, USA
Award details come from USAspending.gov.
Description
- Abstract
- Transcranial magnetic stimulation (TMS) is an FDA-approved treatment for several brain diseases, such as major depressive disorder, obsessive-compulsive disorder, migraine with aura, and smoking cessation. However, the response rate varies significantly across subjects related to several suboptimal treatment parameters such as stimulation intensity and brain target for individual patients. To overcome the limitations, we will develop novel software and computational techniques that integrate real-time navigated electric-field mapping and source- space electroencephalogram (EEG) analysis during TMS to significantly improve the accuracy of targeting and dosimetry for individualized subjects to enhance treatment efficacy. We propose a novel subject-specific target localization method that integrates diffusion MRI tractography and resting-state functional brain networks to select target regions in the dorsolateral prefrontal cortex (DLPFC) and the inferior parietal lobule (IPL) of the frontoparietal network. We will use the electric field and source space EEG mapping techniques to guide the stimulation of the target regions and examine related changes in cognitive control functions. We will complete the proposed work with three aims. In aim 1, we will further develop the slicertms software from our previous work to provide real-time E-field mapping and quantitative measures during TMS treatment. In aim 2, we will incorporate real-time source-space TMS-EEG measures in SLICERTMS2.0 to provide real-time feedback for target engagement and brain activity. In aim 3, we will validate SLICERTMS2.0 online measures by comparing them with standard offline analysis methods with TMS-EEG experiments using the proposed DLPFC and IPL targets. We will also examine TMS-related changes in the choice reaction time in modified multi-source interference tasks. The outcomes of this grant will provide new tools to improve TMS stimulation targeting and dosimetry, which can significantly enhance TMS treatment response for brain diseases.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $751,514 | |
| Original award | $830,409 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The General Hospital Corporation | $611,807 | |
| Isomics Inc. | $71,906 |
Quick answers
Who received award R01MH136160?
R01MH136160 was awarded to Brigham & Womens Hospital Inc. by National Institute of Mental Health (National Institutes of Health) on March 1, 2025.
How much is award R01MH136160 worth?
$1,581,923 has been obligated on R01MH136160.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award